Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website
Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website
This is an increase over the number of companies cited in the previous year.
The citations in the county include:
- Procedures have not been adequately established to control product that does not conform to specified requirements.
- You did not establish and maintain procedures for screening and determining the eligibility of HCT/P donors.
- The accompanying records for HCT/Ps included the donor's name and personal information that might identify the donor.
Both companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Advanced Reproductive Health Center, Chicago IVF, Ltd. | Biologics | 07/05/2023 | Testing, screening, donor eligibility procedures |
Advanced Reproductive Health Center, Chicago IVF, Ltd. | Biologics | 07/05/2023 | Name and personal info on accompanying records |
Advanced Reproductive Health Center, Chicago IVF, Ltd. | Biologics | 07/05/2023 | Abbreviated procedure |
Davryan Laboratories, Inc. | Devices | 10/11/2023 | Nonconforming product, Lack of or inadequate procedures |